Abeona Therapeutics Inc Annual Shareholders Meeting Transcript
Good morning, ladies and gentlemen, and welcome to the 2020 Annual Meeting of the Stockholders of Abeona Therapeutics Inc. I'm Brian Pereira, Executive Chairman of Abeona, and I will be serving as the Chairman of this meeting.
Joining me for today's call is João Siffert, Chief Executive Officer of Abeona. The principal items of business before the meeting are: one, election of 2 Directors, Dr. Todd Wider and Christine Silverstein, to hold office for a term of 3 years and until his or her successor is elected and qualified; two, to approve an amendment to the Abeona Therapeutics Inc. 2015 equity incentive plan to increase the number of shares of our common stock authorized for issuance thereunder from 10 million to 18 million shares; three, to approve the company's nonemployee director compensation plan; four, to ratify the appointment of Whitley Penn LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020; and five, to vote on a shareholder proposal included in the proxy if properly
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |